4D Molecular Therapeutics (FDMT) EBT Margin (2020 - 2026)
4D Molecular Therapeutics' EBT Margin came in at -1924.62% for Q2 2026, up 362055.38 percentage points from -363980.00% a year earlier and up 331.89 percentage points from the prior quarter.
4D Molecular Therapeutics (FDMT) EBT Margin (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, 4D Molecular Therapeutics reported EBT Margin of -194.51%, up 594132.77 percentage points year-over-year; for FY2025, it was -164.39%, up 434405.88 percentage points from FY2024.
- EBT Margin carries a five-year change of +250.78 percentage points (FY2020 to FY2025).
- Going back by year, EBT Margin was -434570.27% in FY2024 (-434084.55 pp), -485.72% in FY2023 (+2948.57 pp), -3434.29% in FY2022 (-3039.59 pp) and -394.70% in FY2021 (+20.46 pp).
- The five-year range for quarterly EBT Margin is -4965000.00% (Q4 2024) to 22.82% (Q4 2025).
- Year-over-year, EBT Margin has increased for five consecutive quarters, with an average year-over-year change of +815937.37 percentage points over the last seven quarters.
- The fastest year-over-year change in EBT Margin over five years came in Q4 2025 (a gain of 4965022.82 percentage points), and the weakest in Q3 2024 (a drop of 1461350.02 percentage points).
- Business Quant data shows FDMT's EBT Margin at -2256.51% (Q1 2026), 22.82% (Q4 2025) and -63172.22% (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | 4D Molecular Therapeutics | 1.02 Bn | -436.78 Mn | - | -1,924.62% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,924.62% |
| Mar 31, 2026 | -2,256.51% |
| Dec 31, 2025 | 22.82% |
| Sep 30, 2025 | -63,172.22% |
| Jun 30, 2025 | -363,980.00% |
| Mar 31, 2025 | -343,135.71% |
| Dec 31, 2024 | -4,965,000.00% |
| Sep 30, 2024 | -1,461,400.00% |
| Jun 30, 2024 | -698,160.00% |
| Mar 31, 2024 | -115,682.14% |
| Sep 30, 2023 | -49.98% |
| Jun 30, 2023 | -12,394.98% |
| Mar 31, 2023 | -9,618.46% |
| Dec 31, 2022 | -2,195.83% |
| Sep 30, 2022 | -5,140.00% |
| Jun 30, 2022 | -17,337.04% |
| Mar 31, 2022 | -2,156.85% |
| Dec 31, 2021 | -27,256.52% |
| Sep 30, 2021 | -1,627.09% |
| Jun 30, 2021 | -52.05% |
4D Molecular Therapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=FDMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "FDMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=FDMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();